Altimmune Inc (NASDAQ:ALT) shares traded -1.65% lower at $9.86 on Wall Street last session.
ALT stock price is now -4.91% away from the 50-day moving average and 85.33% away from the 200-day moving average. The market capitalization of the company currently stands at $529.78M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $13, Goldman recently initiated with Neutral rating for Altimmune Inc (NASDAQ: ALT). On March 22, 2023, Goldman Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $20 to quote $6, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Drutz David, Director bought 300 shares of the company’s stock on Aug 15 ’23. The stock was bought for $862 at an average price of $2.88. Upon completion of the transaction, the Director now directly owns 29,785 shares in the company, valued at $0.29 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 24 ’23, Chief Financial Officer Eisenstadt Richard I bought 10,000 shares of the business’s stock. A total of $43,140 was incurred on buying the stock at an average price of $4.31. This leaves the insider owning 22,010 shares of the company worth $0.22 million. A total of 1.02% of the company’s stock is owned by insiders.
During the past 12 months, Altimmune Inc has had a low of $2.09 and a high of $14.84. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 12.89, and a quick ratio of 12.89. The fifty day moving average price for ALT is $10.37 and a two-hundred day moving average price translates $5.35 for the stock.
The latest earnings results from Altimmune Inc (NASDAQ: ALT) was released for Sep, 2023. According to the Biotechnology Company, earnings per share came in at -$0.39, beating analysts’ expectations of -$0.42 by 0.03. This compares to -$0.48 EPS in the same period last year. The net profit margin was -28124.01% and return on equity was -44.15% for ALT. The company reported revenue of $0.36 million for the quarter, compared to $2000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 18000.0 percent.
